← Back to catalogue

B Probe 15MHz COMPACT TOUCH

FDA UDI

Class II (US FDA UDI)

by Quantel Medical

Identity

Trade Name
B Probe 15MHz COMPACT TOUCH FDA UDI
Generic Name
Ophthalmic ultrasound imaging transducer FDA UDI
Device Name
15 MHz Probe for eye and orbit examination. Automatic biometry readings obtained from a B mode image allowing axial length measurements for difficult to mesure long eyes or posterior staphyloma. FDA UDI
Model / Reference
B1 COMPACT TOUCH 2017 FDA UDI
Description
15 MHz Probe for eye and orbit examination. Automatic biometry readings obtained from a B mode image allowing axial length measurements for difficult to mesure long eyes or posterior staphyloma. FDA UDI

Identifiers

Primary DI / UDI-DI
03700542625538 FDA UDI
510(k) Number
K180265 FDA UDI
FDA Product Code
ITX FDA UDI
GMDN Term
Ophthalmic ultrasound imaging transducer FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.1570 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Ophthalmic ultrasound imaging transducer

B Probe 15MHz COMPACT TOUCH by Quantel Medical — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Ophthalmic ultrasound imaging transducer.

Cleared under the same submission

K180265 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Quantel Medical

Sources (1)

  • FDA UDI 45c736ed-f4b3-4a50-82cf-e53f6197f5df 35 fields · synced Jun 8, 2026